UNSPSC 51162103: Isoniazid/rifampin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM500. This VA Drug Class (AM500) classifies this compound as belonging to the group ANTITUBERCULARS.

UNSPSC 51162103 Isoniazid/rifampin is a Commodity code that nominally covers tuberculosis medications, but recent state and local solicitations under this code do not actually purchase isoniazid/rifampin or any tuberculosis treatments. Instead, the code has been applied to naloxone procurement and on-site pharmacy services — neither of which aligns with the code's stated scope. The mismatch suggests either miscoding in the issuing bodies' procurement systems or a jurisdictional interpretation of the code that deviates materially from its intended taxonomy. State and local governments tagging work to this code are primarily counties and special-purpose health districts sourcing emergency opioid-reversal products and employer-sponsored pharmacy operations rather than antituberculous drugs.

Recent activity appears limited to Florida and Georgia. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually on a competitive bid basis, with a response deadline of July 26, 2023 (note: date appears retroactively entered). Hall County, Georgia issued RFQ/P #47-010 in May 2026 to engage a single on-site pharmacy services provider for the Hall County Government Family Health Center Clinic, requiring vendors to stock and dispense a formulary of 25 medications across multiple therapeutic categories to approximately 3,005 eligible individuals, with responses due June 4, 2026. No other jurisdictions or states appear in the recent-opportunities block. The mismatch between the code's nominal scope and actual recent purchasing activity suggests this code carries limited relevance for firms focused on tuberculosis pharmaceutical supply.